NCT06991322View on ClinicalTrials.gov

Self-Expanding Coronary Sinus Reducer for Treatment of Symptomatic Coronary Microvascular Dysfunction (CMD) (SERRA-I Study)

NARecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

June 18, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

April 30, 2027

Conditions
Coronary Microvascular DysfunctionCoronary Microvascular Disease
Interventions
DEVICE

A-FLUX Reducer System

The VahatiCor A-FLUX Reducer System is an implantable, self-expanding dense-cell nitinol coronary sinus flow restrictor device pre-loaded into the A-FLUX Delivery Catheter.

Trial Locations (1)

3584

RECRUITING

University Medical Center Utrecht, Utrecht

All Listed Sponsors
lead

VahatiCor, Inc.

INDUSTRY